Skip to content

NIAGEN BIOSCIENCE, INC.: 10-Q filed 2012-11-08

What NIAGEN BIOSCIENCE, INC. reported in its quarterly report filed 2012-11-08 (fiscal Q3 2012): 36 published measures, 95 facts as tagged in accession 0001415889-12-001612.

This filing

Form
10-Q (quarterly report)
Filed
2012-11-08
Fiscal period
fiscal Q3 2012
Accession
0001415889-12-001612 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NIAGEN BIOSCIENCE, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-09-299,430,621USD
At 2011-12-316,269,905USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-09-295,229,080USD
At 2012-06-305,603,438USD
At 2012-03-318,265,658USD
At 2011-12-312,561,286USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-29-1,538,034USD91
2012-01-01 to 2012-09-29-9,963,844USD273
2012-04-01 to 2012-06-30-3,993,957USD91
2012-01-01 to 2012-03-31-4,431,853USD91
2011-07-03 to 2011-10-01-2,404,912USD91
2011-01-02 to 2011-10-01-5,403,866USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-09-29-9,369,871USD273
2011-01-02 to 2011-10-01-2,497,791USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-09-2913,764USD273
2011-01-02 to 2011-10-01126,369USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-09-2910,252,554USD273
2011-01-02 to 2011-10-012,493,009USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-09-29-65,764USD273
2011-01-02 to 2011-10-01-152,369USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-09-29-28,018,030USD
At 2011-12-31-18,054,186USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-07-01 to 2012-09-2992,364,418shares91
2012-01-01 to 2012-09-2989,477,758shares273
2011-07-03 to 2011-10-0170,625,913shares91
2011-01-02 to 2011-10-0166,190,731shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-07-01 to 2012-09-2998,358,485shares91
2012-01-01 to 2012-09-2995,386,249shares273
2011-07-03 to 2011-10-0178,299,798shares91
2011-01-02 to 2011-10-0174,082,647shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-09-29987,732USD
At 2011-12-311,172,288USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-09-292,189,917USD273
2011-01-02 to 2011-10-012,469,827USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-07-01 to 2012-09-29-1,531,638USD91
2012-01-01 to 2012-09-29-9,943,877USD273
2011-07-03 to 2011-10-01-2,397,685USD91
2011-01-02 to 2011-10-01-5,380,421USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-09-298,269,893USD
At 2011-12-314,953,352USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-07-01 to 2012-09-296,865USD91
2012-01-01 to 2012-09-2922,692USD273
2011-07-03 to 2011-10-017,522USD91
2011-01-02 to 2011-10-0124,604USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-09-293,900,573USD
At 2011-12-313,343,000USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-09-292,838,988USD
At 2011-12-312,250,241USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-09-291,203,429USD
At 2011-12-31723,666USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-07-01 to 2012-09-292,785,891USD91
2012-01-01 to 2012-09-2911,358,610USD273
2011-07-03 to 2011-10-012,864,152USD91
2011-01-02 to 2011-10-017,448,202USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-09-295,436,439USD
At 2011-12-312,905,600USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-07-01 to 2012-09-291,254,253USD91
2012-01-01 to 2012-09-291,414,733USD273
2011-07-03 to 2011-10-01466,467USD91
2011-01-02 to 2011-10-012,067,781USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2012-07-01 to 2012-09-292,377,991USD91
2012-01-01 to 2012-09-296,673,127USD273
2011-07-03 to 2011-10-011,361,101USD91
2011-01-02 to 2011-10-014,237,008USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-09-2991,650,062shares
At 2011-12-3172,939,996shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-09-2933,155,460USD
At 2011-12-3120,542,532USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-09-293,311,694USD
At 2011-12-313,259,887USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-09-292,323,962USD
At 2011-12-312,087,599USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2012-09-29140,829USD
At 2011-12-31100,106USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-09-29172,996USD
At 2011-12-31144,265USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-09-29664,771USD
At 2011-12-31755,967USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-291,983,720USD91
2012-01-01 to 2012-09-296,829,359USD273
2011-07-03 to 2011-10-012,213,636USD91
2011-01-02 to 2011-10-015,786,204USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-09-29247,227USD273
2011-01-02 to 2011-10-01247,024USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2012-01-01 to 2012-09-2911,277USD273
2011-01-02 to 2011-10-0155,843USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-07-01 to 2012-09-29-6,396USD91
2012-01-01 to 2012-09-29-19,967USD273
2011-07-03 to 2011-10-01-7,227USD91
2011-01-02 to 2011-10-01-23,445USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-09-2910,159,838USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-29-2,530,839USD273
2011-01-02 to 2011-10-01-1,077,763USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-29588,747USD273
2011-01-02 to 2011-10-01791,949USD273

Inspect the source

Entity
NIAGEN BIOSCIENCE, INC. / CIK 0001386570
Captured
2026-09-20T07:59:02.162Z
SEC response SHA-256
94352bf8b6f04074c9aa98cd63fa97055bc3335ae039584aee12f63320ac36f6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001386570.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))